Immunic (IMUX) Stock News
$IMUX · NASDAQ · 2 stories in 30 days$6.97
1D −1.90%1W −11.89%1M −38.65%
BORSA has published 2 stories on Immunic (IMUX) in the past 30 days. BORSA’s news read on IMUX is balanced at 50/100, unchanged over 24 hours, based on 1 company event over the past 7 days. IMUX last closed at $6.89 on Oct 13, down 11.89% over five sessions and down 38.65% over the past month. Immunic’s next earnings report is scheduled for Thursday, Nov 12.
The wire on $IMUX
newest first · updated · direct subject stories onlyImmunic grants inducement equity awards to three new employees under Nasdaq rule
Immunic granted inducement stock options covering 12,900 shares to three new employees. The options vest over time and are standard for new-hire inducement under Nasdaq rules. No change to clinical pipeline or financial outlook.
neutral 50 · impact 10